ERBB2 and breast carcinoma: These include nuclear estrogen receptor (ER), progesterone receptor (PR) and surface membrane bound human epidermal growth factor receptor 2 (HER2), with 85–90% of breast cancer overexpressing one or more of these receptors (1, 2).